KARL HEINZ BRISCH: Treating Attachment Disorders: From Theory to Therapy. Guilford Press, New York, 2002, 294 pp., $36.90, ISBN 1-57230-681-5. The author, a German psychoanalyst, attempts to demonstrate the applicability and efficacy of attachment-theory concepts in a wide variety of clinical...
Operating on the belief that a framework of complex traumatic stress disorders enables clinical practices to take effect, authors Courtois and Ford present a collection of papers that, from an empirical approach, indicate how trauma victims can be effectively treated. Divided into three sections, ...
Interpersonal Stress Regulation and the Development of Anxiety Disorders: An Attachment-Based Developmental Framework Anxiety disorders represent a common but often debilitating form of psychopathology in both children and adults. While there is a growing understanding of ... N Tobias,G Jo,F Peter,.....
Currently, onlydexmethylphenidateextended release (XR), mixed-amphetamine salts-extended release (MAS-XR), andatomoxetinehave received US Food and Drug Administration (FDA) approval for use in adults for the treatment of symptoms of ADHD, although other forms ofstimulantmedication and some nonstimulant...
Personality disorders (PD) are described as enduring patterns of markedly deviant and pervasive inner experiences and behaviors, with onset in adolescence, which lead to severe distress or impairment. Patients suffering from major depressive disorder (MD
Sensory sensitivity, attachment experiences, and rejection responses among adults with borderline and avoidant features Both avoidant and borderline personality disorder (APD and BPD) are theoretically associated with temperamental vulnerabilities, adverse attachment experie... B Meyer,M Ajchenbrenner,DP ...
factor (NSF) attachment protein receptor (SNARE)-dependent manner.83 The nanoscale exosomes can easily shuttle through tissues and biological barriers to transfer microRNAs, lipids, and proteins, thus they have been adapted as therapeutic agents.84For example, exosomal miR-125b-5p was shown to ...
Anxiety disorders are extremely common. According to theNational Institute of Mental Health,just over 31% of American adults experience an anxiety disorder at some point, and theWorld Health Organization estimatesthat the global prevalence of anxiety and depression increased by 25% in the first year ...
In higher income countries, these are comparatively (although perhaps not sufficiently) widely available: NHS Improving Access to Psychological Therapies (IAPT) services in the UK currently reach around 25% of adults with anxiety disorders and depression (NHS England, 2021). There is much evidence ...
The present disclosure provides a particular bioactive polypeptide hormones of the insulin family and it's homologs as drug-conjugates that are effective therapeutics for metabolic disorders, including, but not limited to, Type 2 diabetes, Insulin resistance, metabolic syndrome and type 1 diabetes. ...